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ABSTRACT
Background: HIV testing and knowledge of status are
starting points for HIV treatment and prevention
interventions. Among female sex workers (FSWs), HIV
testing and status knowledge remain far from
universal. HIV self-testing (HIVST) is an alternative to
existing testing services for FSWs, but little evidence
exists how it can be effectively and safely implemented.
Here, we describe the rationale and design of a cluster
randomised trial designed to inform implementation
and scale-up of HIVST programmes for FSWs in
Zambia.
Methods: The Zambian Peer Educators for HIV Self-
Testing (ZEST) study is a 3-arm cluster randomised
trial taking place in 3 towns in Zambia. Participants
(N=900) are eligible if they are women who have
exchanged sex for money or goods in the previous
1 month, are HIV negative or status unknown, have not
tested for HIV in the previous 3 months, and are at
least 18 years old. Participants are recruited by peer
educators working in their communities.
Participants are randomised to 1 of 3 arms: (1) direct
distribution (in which they receive an HIVST from the
peer educator directly); (2) fixed distribution (in which
they receive a coupon with which to collect the HIVST
from a drug store or health post) or (3) standard of
care (referral to existing HIV testing services only,
without any offer of HIVST). Participants are
followed at 1 and 4 months following distribution of
the first HIVST. The primary end point is HIV testing in
the past month measured at the 1-month and 4-month
visits.
Ethics and dissemination: This study was approved
by the Institutional Review Boards at the Harvard T.H.
Chan School of Public Health in Boston, USA and
ERES Converge in Lusaka, Zambia. The findings of this
trial will be presented at local, regional and
international meetings and submitted to peer-reviewed
journals for publication.
Trial registration number: Pre-results;
NCT02827240.
INTRODUCTION
Female sex workers (FSWs), deﬁned as
women who exchange sex for money or
goods, bear a disproportionate burden of the
HIV epidemic globally.1 2 Global HIV preva-
lence among FSWs has been estimated at
nearly 12%, with HIV prevalence rising to
more than 30% for FSWs living in countries
with medium and high background HIV epi-
demics.1 In sub-Saharan Africa in 2011, an
estimated 17.8% of all infections in women
were attributed to engagement in sex work.3
Vulnerability to HIV among FSWs occurs at
multiple levels,4 which potentiates the HIV
epidemic in this population.2 5 Determinants
of HIV among FSWs occur at the individual
level (behavioural and biological factors,
such as sexually transmitted infections), dyad
Strengths and limitations of this study
▸ This study will be one of the first reporting the
effectiveness and safety of an HIV self-testing
(HIVST) intervention among female sex workers
(FSWs).
▸ The results will allow for assessment of the
feasibility and acceptability of HIV self-test kits
in general.
▸ The results will provide evidence on whether
HIVST is used by FSWs if it is accessible via
existing distribution points within the health
system.
▸ Limitations of this study include the self-
reported nature of many of the outcomes, which
may lead to social desirability biases.
▸ To overcome social desirability biases in the
reporting of outcomes, in particular the use of
HIVST and HIV status knowledge, we use
several innovative measurement approaches.
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and partner level (such as power dynamics within rela-
tionships), work environment level (organisational struc-
tures where individuals work, including venue policies
and availability of condoms in venues),6 and community
and macrostructural levels (including community
structure and organisation and legal and policy
environments).2
In 2014, the Joint United Nations Programme on HIV
and AIDS (UNAIDS) put forth a new global target for
controlling and ultimately ending the HIV epidemic.7
The 90-90-90 target is a three-part target that aims to
have 90% of people living with HIV aware of their
status, 90% of those diagnosed on treatment and 90%
of those on treatment virally suppressed by the year
2020, ultimately resulting in viral suppression for 73% of
HIV-infected individuals worldwide. Such a strategy
requires regular HIV testing for individuals who are at
ongoing risk of HIV, including FSWs. However, signiﬁ-
cant gaps remain in HIV testing coverage in sub-Saharan
Africa.8 Given the large burden of HIV among FSWs
and the unique barriers to HIV prevention faced by this
population, evidence of strategies that are speciﬁcally
designed for this population is urgently needed.
Stigma and discrimination can affect access to HIV
testing among FSWs.9 10 FSWs may be affected by mul-
tiple intersecting forms of stigma. Stigma is broadly
deﬁned as negative attitudes, relative powerlessness and
loss of status related to a particular characteristic.9
Stigma can be experienced as enacted (explicit actions
such as derogatory language, active discrimination or
assault), perceived (the expectation of enacted stigma)
or self-stigma (internalisation of stigma).10 For FSWs,
stigma can be due to engagement in sex work itself, or
from HIV stigma, particularly in contexts of high HIV
burden, and can come from family or other community
members, partners and healthcare providers. These
experiences of stigma may be exacerbated by unequal
power dynamics, poverty and ﬁnancial reliance on sex
work, and experiences of violence. Taken together, the
multidimensionality of experiences of stigma and dis-
crimination may greatly inﬂuence uptake of HIV testing.
Interventions that mitigate stigma as a barrier to HIV
testing may be especially powerful for FSWs.
Oral HIV self-testing (henceforth, HIVST) is an alter-
native to clinic or other healthcare provider testing (eg,
home-based HIV testing and counselling) that may over-
come some barriers to traditional HIV testing strategies
for some populations.11–14 HIVST has been shown to be
acceptable in a variety of populations globally,11 but very
little data exist on the acceptability and feasibility of
HIVST among FSWs.13 For FSWs in particular, HIVST
may be a particularly good option as it offers privacy
protection, efﬁciency and ﬂexibility. FSWs are a vulner-
able population regarding potential harms and threats
to livelihood if others are to learn they are HIV positive.
HIVST may offer an additional degree of privacy by
allowing women to test in a place of their choosing.
HIVST may be efﬁcient for FSWs. Current
recommendations indicate that FSWs should ideally test
for HIV every 3 months. HIVST could reduce the
burden of transport to clinics for traditional testing.
Finally, HIVST is ﬂexible. Existing clinics may not offer
HIV testing services during hours which are feasible for
FSWs, who often sleep during the day and work during
the night. HIVST can overcome each of these limitations
by allowing a woman to test at a time and a place that is
convenient and acceptable to her.
A rapid oral HIVST has been approved in the USA,
which uses ﬂuid from the oral mucosa and is read in
20 min.15 The test, OraQuick (OraSure Technologies,
Bethlehem, Pennsylvania, USA), has a sensitivity of
91.7% and a speciﬁcity of 99.9% among untrained
users.16 All individuals who test positive with this test are
encouraged to get a blood-based conﬁrmatory test.
Among men who have sex with men in Seattle, a rando-
mised controlled trial demonstrated a signiﬁcant
increase in HIV testing coverage among individuals
receiving HIVST.17 Although HIVST may be an accept-
able alternative to regular HIV testing for FSWs,
minimal evidence of the use of HIVST among FSWs
exists.18 The acceptability, uptake, and effectiveness and
safety of HIVST among FSWs remain largely unknown.
Here, we describe a cluster randomised controlled
trial that addresses this critical gap in the HIVST evi-
dence for FSWs. In the trial, we test two health service
delivery approaches, a direct distribution system where
an FSW participant is directly given an HIVST by a peer,
and a ﬁxed distribution system where the FSW partici-
pant collects the HIVST from a ﬁxed point such as a
pharmacy or health post. The trial seeks to determine
the effectiveness and safety of these two HIVST delivery
approaches, compared with standard of care, for improv-
ing HIV testing coverage and knowledge of HIV status.
METHODS/DESIGN
Theory of change
The intervention tested in the Zambian Peer Educators
for HIV Self-Testing (ZEST) study, as well as data col-
lected throughout the course of the study, was guided a
priori by a theory of change developed through mental
models and deductive development.19 Brieﬂy, we
theorised that the distribution of HIV self-test kits via
peer educators would lead to improved status knowledge
by reducing barriers to HIV testing such as stigma hours
of clinic operation. Enacted or perceived sex work
stigma from healthcare providers and from the commu-
nity may be addressed by HIVST, by allowing individuals
to test for HIV in private without fear of being seen in
the clinic and without fear of judgement from providers.
This would lead to improved uptake of HIV testing,
which would lead to improved knowledge of status and
ultimately reduce time to linkage to care. However, it is
also possible that a community-based intervention such
as HIVST could be unsuccessful if individuals are con-
cerned about others discovering their HIV status.
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Study design
This is a unmasked cluster randomised trial.
Individuals are enrolled as members of a peer educator
group, with a target enrolment of six FSWs per peer
educator (with ﬁve allowed if there are recruitment dif-
ﬁculties). The peer educator–FSW group is randomised
in a 1:1:1 fashion to one of the three study arms: (1)
peer educator distribution of HIVST directly to parti-
cipants (direct distribution), (2) peer educator dis-
tribution of a coupon valid for an HIVST at a ﬁxed
distribution point (ﬁxed distribution) or (3) standard
of care. Participants will be followed for 4 months from
enrolment, with follow-up assessments at months 1 and
4 (ﬁgure 1).
Specific aims
The speciﬁc aims of this trial are to: (1) establish the
effectiveness of two different distribution approaches
(direct and ﬁxed distribution) for increasing HIV testing
coverage among FSWs; (2) establish the effectiveness of
the two distribution approaches on increasing HIV status
knowledge among FSWs; (3) measure HIVST uptake by
distribution approach and (4) measure linkage to care
by the different approaches. Additionally, the trial will
measure the impact of HIVST using the two distribution
approaches on a number of important safety end points.
The trial design will allow for a comparison of the two
distribution approaches to each other as well as to stand-
ard HIV testing.
Study oversight
An independent Scientiﬁc Oversight Committee (SOC)
oversees the data collected as part of this study. The
SOC contains members with expertise in HIV epidemi-
ology, statistics, ethics and female sex work. The SOC
reviews any reports of serious adverse events during the
course of the trial, and will convene a meeting after
approximately one-third of the participants have
reached their 1-month visit. Owing to the short duration
of the study, there are no formal statistical stopping
rules.
Setting
This study is taking place in three border and transit
towns in Zambia: Chirundu, Livingstone and Kapiri
(ﬁgure 2). Chirundu and Livingstone are located on the
Zambia–Zimbabwe border, and are major transportation
points for people and goods. Kapiri is north of the
capital, Lusaka, and is a transit hub, with a large weigh
station where many truckers stop for the night or longer.
Study headquarters and coordination for the three sites
is located in the capital, Lusaka.
Recruitment
Participants are recruited by peer educators. The peer
educators are current or former FSWs themselves who
were recruited by study staff and who have undergone a
2-day training in study procedures and HIVST. Peer edu-
cators, who are not considered as participants in this
study, were recruited from current and former sex work
organisations working in each of the study towns.
Interested potential participants are referred to study
staff after the peer educator describes the study to them.
A research assistant then conducts a phone screening to
determine whether or not the participant is eligible.
Formal eligibility assessments are done in person at
Figure 1 Flow diagram of study enrolment, randomisation and intervention arms. FSW, female sex worker; HIVST, HIV
self-testing; STD, sexually transmitted disease; IPV, intimate partner violence.
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which point the research assistant and eligible indivi-
duals complete an informed consent procedure. Written
informed consent is obtained from all participants.
Inclusion and exclusion criteria
Complete inclusion and exclusion criteria are sum-
marised in table 1. Participants must be women 18 years
of age or older who self-report exchanging sex (includ-
ing vaginal, anal and/or oral) for money or goods in
the past month.
Individuals who are currently residing in the PopART
study catchment area20 in Livingstone will be excluded
from this study, in addition to any individual who
reports concomitant enrolment in another HIV
prevention study. The PopART study includes a house-
hold HIV testing programme, which would bias out-
comes in this study if individuals were being regularly
tested as part of another HIV prevention study.
Randomisation
Peer educator groups (the 5–6 women recruited by a
particular peer educator and enrolled in the study) are
randomised as a unit. Group randomisation occurs after
all members of the group have been enrolled in the
study and completed their baseline questionnaire.
Groups are randomised to one of the three study arms
using a computer-generated randomisation list in
random blocks of 3, 6 and 9 and stratiﬁed by study site
Figure 2 Map of study sites in Zambia. The black star indicates Lusaka, the site of study coordination and headquarters. The
circles indicate locations of study sites, including Kapiri (blue), Chirundu (green) and Livingstone (red).
Table 1 Study inclusion/exclusion criteria
Inclusion criteria Exclusion criteria
▸ 18 years or older at enrolment ▸ <18 years at enrolment
▸ Reports exchanging sex (vaginal, oral and/or anal) for money or goods
at least once in the past month
▸ Has not exchanged any form of sex in the
past month
▸ Self-reported HIV negative and no recent HIV test (<3 months) OR HIV
status unknown
▸ Self-reported to be living with HIV
▸ Self-reported HIV negative but tested within
the past 3 months
▸ Permanent residence in the study town of enrolment (Livingstone,
Chirundu, Kapiri)
▸ Planning to move out of the geographical
area within 4 months
▸ Living in the PopART catchment area
(Livingstone only)
▸ Willing to participate in peer education sessions and study
assessments over a 4-month study period
▸ Meets inclusion criteria but does not wish to
participate
▸ Concurrently participating in another HIV
prevention study
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(Livingstone, Chirundu and Kapiri). Randomised study
arm assignments are placed in an opaque envelope, and
once all participants in a peer educator group have
been enrolled, the research assistant obtains the enve-
lope from the research coordinator or the site coordin-
ator and opens the envelope with the peer educator.
Study procedures
An overview of the study procedures and activities is
summarised in table 2 and ﬁgure 3.
Peer educator visits
In all study arms, peer educators will meet with partici-
pants at least four times (approximately monthly) over
the course of the study. The ﬁrst peer educator interven-
tion visit (intervention visit 1) will be a group-based visit,
and includes simple HIV prevention information, infor-
mation on where to go for HIV testing and condom pro-
vision. The initial group-based intervention is organised
by the peer educator with assistance from the research
assistant, and occurs in a private location of mutual
convenience for the group members (such as a study
ofﬁce, or near a work place). In the HIVST arms, peer
educators will provide a brief overview of how to use the
self-test kits, whom to contact if participants have pro-
blems or concerns, and the importance of as well as how
to obtain additional care, including conﬁrmatory testing
and linkage to care. Follow-up visits (intervention visits
2–4) with peer educators comprise brief one-on-one
check-in visits, during which peer educators will distrib-
ute condoms, discuss any issues participants have with
the HIVST kits or other elements of the study, and
screen for adverse events including intimate partner vio-
lence. Between visits, peer educators will be available
should participants need help with any issue relating to
safe sex, HIV, violence or any other elements of the
study. Peer educators do not speciﬁcally discuss HIV
status with any participant unless the participant seeks
out the peer educator for advice. Participants are given
alternatives should they need help with HIVST or
another element of the study but do not want to disclose
their HIV status to the peer educator. In particular,
Table 2 Outline of study visits
Study time point Visit by Activities
Recruitment Peer educator ▸ Peer educator discusses study with potentially eligible participant
and refers them to study staff
Enrolment Research
assistant
▸ Assessment of eligibility
▸ Informed consent (if eligible)
▸ Baseline quantitative survey
▸ Baseline qualitative survey (∼5%)
Randomisation Research
assistant
▸ Randomisation of peer educator and their cohort of participants
once all group members are enrolled
Intervention visit 1 (week 0) Peer educator ▸ Group-based intervention
▸ HIV prevention counselling and distribution of condoms
▸ Training on HIV self-test use (in HIVST arms)
▸ Distribution of HIV self-tests or coupons (in HIVST arms)
Intervention visit 2 (weeks 2–3) Peer educator ▸ Screening for adverse events
▸ Discussion of any difficulty with HIV self-test use (in HIVST arms)
▸ Referral to care and standard HIV testing
▸ Distribution of condoms
One-month visit (weeks 4–5) Research
assistant
▸ One-month quantitative survey
▸ One-month qualitative survey (∼5%)
▸ Screening for adverse events
Intervention visit 3 (weeks 6–7) Peer educator ▸ Screening for adverse events
▸ Discussion of any difficulty with HIV self-test use (in HIVST arms)
▸ Referral to care and standard HIV testing
▸ Distribution of condoms
Intervention visit 4 (weeks 10–12) Peer educator ▸ Screening for adverse events
▸ Discussion of any difficulty with HIV self-test use (in HIVST arms)
▸ Referral to care and standard HIV testing
▸ Distribution of condoms
▸ Distribution of second HIV self-test or coupon (in HIVST arms)
Four-month visit (weeks 16–18) Research
assistant
▸ Four-month quantitative survey
▸ Four-month qualitative survey (∼5%)
▸ Screening for adverse events
▸ HIV status assessment
HIVST, HIV self-testing.
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participants in all study arms also have access to an
anonymous 24-hour hotline provided via the study.
Participants will be instructed by the research assistant
that they can call the 24-hour hotline at any time if they
have difﬁculty with using the HIV self-test kit, need
counselling related to HIV testing or gender-based vio-
lence, or need any other form of assistance over the dur-
ation of the study.
Direct distribution arm
In the direct distribution arm, peer educators will dir-
ectly distribute HIVST kits to participants during the
ﬁrst intervention visit. The HIVST kit consists of a single
OraQuick in-home HIV self-test and instructions trans-
lated into English, Nyanja and Bemba. The instructions
are a step-by-step pictorial and written guide for using
the test and interpreting the results.
Peer educators offer a second HIVST kit to partici-
pants in the direct distribution arm at the fourth inter-
vention visit. There is no HIV status requirement for
distribution of a second test. The second test is distribu-
ted at the last peer educator visit, 3 months after the
ﬁrst, to minimise contamination of study arms.
Fixed distribution arm
In the ﬁxed distribution arm, peer educators give parti-
cipants a coupon which they can exchange for an
HIVST kit at a participating ﬁxed distribution facility.
These facilities include drug stores and health posts that
have agreed to participate in the study and have received
basic training on HIVST. Staff at the ﬁxed distribution
points collect the coupons when they are exchanged for
an HIVST kit and give them to research staff on a
weekly basis. These coupons include a bar code that is
scanned by study staff to record which participants col-
lected the HIVST kit.
Peer educators offer a second coupon to participants
at the fourth intervention visit to individuals, similar to
the direct distribution arm, which can be used to obtain
the second HIVST kit.
Standard of care arm
In the standard of care arm, peer educators give partici-
pants information about existing HIV testing services
where participants can go for testing. In Livingstone,
Chirundu and Kapiri, available options generally
include government facilities, non-proﬁt faith-based
facilities and private facilities. While clinics designed spe-
ciﬁcally for FSWs were previously in operation in these
cities, funding constraints forced these facilities to close
in 2015. The information that participants receive about
HIV testing facilities is customised to the city of their
recruitment, and identical information is given to parti-
cipants in each of the three arms.
In all study arms, participants will receive a linkage to
care card from their peer educator that they will be
requested to bring if they seek conﬁrmatory testing and
HIV care.
Figure 3 SPIRIT flow chart of
study assessments. HIVST, HIV
self-testing.
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Data collection
Baseline survey: enrolment
At the enrolment visit, all participants complete a quantita-
tive questionnaire administered by a research assistant.
Quantitative data are collected directly on a tablet. All
assessments are conducted in a private room at a time and
location that is convenient to the participant. The baseline
survey covers broad topics including demographics and
household composition, sex work and professional history,
reproductive health and contraception, sexual behaviours,
HIV testing history, attitudes towards HIVST, access to
healthcare, and measures of substance use,21 depression,22
social support, self-efﬁcacy,23 and empowerment.24
One-month and 4-month visits
Follow-up surveys will be conducted at the 1-month and
4-month visits from intervention visit 1 (see table 2). As
with the baseline survey, all quantitative data will be col-
lected via a tablet, and qualitative data (4-month visit only)
are collected via an audio recorder. Participants in all arms
of the study will be asked about their recent HIV testing
history, sexual behaviours, access to healthcare and linkage
to care. In the HIVST arms of the study, participants will
additionally be asked about their experiences with the
HIVST kit, including if they used it and details about their
experience using the test, as well as their experience with
the peer educator. Participants in all arms are asked again
at 1 and 4 months about HIVST acceptability and per-
ceived likelihood of using such tests in the future.
Qualitative interviews
Approximately 5% of the sample (15 participants per arm,
45 in total) are randomly selected at baseline to participate
in individual qualitative in-depth interviews. During baseline
screening, a random subset of participants will be asked if
they would be interested in participating in the qualitative
phase of the study. Individual in-depth interviews are con-
ducted by trained research assistants at baseline and at the
4-month follow-up visit (table 2). All qualitative data are col-
lected via an audio recorder. Baseline interviews explore
community norms related to HIV testing, multilevel
(including individual, structural and interpersonal) barriers
to accessing HIV testing and other healthcare, experiences
in sex work, and baseline perceptions of HIVST. At
follow-up, qualitative interviews focus on experiences using
the HIV self-test for individuals who are in one of the two
intervention arms, and individuals in all arms will be asked
about their perceptions of the HIV self-test and how HIVST
might be implemented at scale. In all arms at follow-up, the
interviews will explore empowerment and self-efﬁcacy
related to HIV testing and HIV status disclosure.
End point measurement
Study effectiveness and safety end points are summarised
in table 3. The primary effectiveness end point for the
study is the proportion of participants who tested in the
previous month as assessed at the 1-month follow-up
visit. Secondary effectiveness end points include testing
at 4 months, awareness of HIV status, HIVST kit use
(restricted to the HIVST arms), linkage to care and
adverse events. Safety end points include intimate
partner violence and mental health.
Recent HIV testing
Recent HIV testing is assessed by self-report at the
1-month and 4-month visits. Participants are asked when
Table 3 Summary of study end points
End point Operationalisation
Primary effectiveness end point
Tested for HIV in the past
month
Recent HIV testing measured by asking participants when they last tested and where (in all
arms of the study)
Secondary effectiveness end points
Use of HIV self-test Measured by buying back unused HIV self-tests at the 4-month visit
Awareness of HIV status Measured using a three-step approach: (1) asking participants if they know what their status
is; (2) offering participants a small financial gift if they can correctly tell the interviewer what
their HIV status is; 3) confirming HIV status with a rapid test
Linkage to care and
confirmatory testing
Measured in two ways: (1) during follow-up visits, asking participants if they received
confirmatory testing and linked to care; and (2) collection of referral cards linking individual
HIV self-tests to individuals via a unique identification number
Sexual behaviours Measured via CAPI, including number of sexual behaviours, event-level sexual behaviour
data, and condom use with primary and casual partners
Safety end points
Misuse of HIV self-tests ▸ Including difficulty conducting the test (ie, mistakes in taking the test, incorrect use of
components of the test), difficulty reading the test
▸ Identified through interview and ongoing consultation with peer educators
Intimate partner violence ▸ Measured through surveillance and interviews by research assistants
▸ Any intimate partner violence (including verbal, physical or sexual) will be documented
and reported
CAPI, computer-assisted personal interview.
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their last HIV test was, and then asked where their test
was to determine if their last test was an HIVST or other.
HIV status knowledge
Correct reporting of HIV status via a self-report is
subject to social desirability bias. To accurately measure
whether an individual knows their HIV status, they must
both correctly report knowledge of their HIV status and
be willing to take an HIV test. To overcome some of the
bias in ascertaining self-reported HIV status, we use a
three-step approach. First, participants are asked if they
know their current HIV status. They are then asked to
tell the research assistant their current HIV status, and
are told to take their best guess if they do not know.
Participants are then asked to take a rapid HIV test, and
are counselled that this test is entirely voluntary. To
reduce bias in self-reporting HIV status, participants are
told that they will receive a small gift (worth ∼US$1) if
they correctly report their status. However, after the
assessment, all participants will receive the gift regardless
of their reported status; thus, the cash transfer is per-
ceived as conditional but is actually unconditional for
ethical reasons. Pretest and post-test counselling will be
available to all individuals who participate in the HIV
status assessment. This assessment is performed only at
4 months.
HIVST kit use
Actual use of the HIVST kit may also be subject to social
desirability bias. Participants may want to report that
they used the HIVST kit when they did not for many
reasons, including a desire to please the researchers, a
sense of obligation or misperception about what it
means to use the test.25 As an attempt to reduce bias in
ascertainment of actual use of the HIVST kits, research
assistants will ask participants to buy back any unused
HIVST kits at the end of the study with the justiﬁcation
that the study has now reached completion. Participants
will be offered ∼US$1 in exchange for any unused test
kits in their original packaging. Prior to this offer, parti-
cipants are not told that researchers will buy back tests
at the end of the study (this information is also not
included in the informed consent). To avoid gossip
among study participants, the ﬁrst buy-back will not
happen until at least 1 month after the last test kit has
been distributed (with the assumption that all partici-
pants would have used the test kit at that point if they
were planning to).
Stigma and empowerment
Stigma and empowerment are measured both quantita-
tively and qualitatively at baseline and 4 months.
Empowerment is measured additionally at 1 month.
Quantitatively, sex work stigma is measured via a six-item
scale that covers enacted, perceived and self-stigma,26
and HIV stigma is measured by a nine-item scale meas-
uring attitudes towards individuals living with HIV.27
Qualitatively, stigma measurements include questions
related to barriers to accessing care, interactions with
police and experiences working as a sex worker. We
hypothesise that at baseline individuals who report a
greater amount of stigma will have reduced HIV testing,
and that these individuals will have greater uptake of
HIVST. Empowerment is deﬁned as the process by
which disenfranchised individuals acquire the ability to
make choices.24 Quantitatively, empowerment is mea-
sured with a ﬁve-item scale addressing sex worker agency
and power within.24 Qualitatively, empowerment is mea-
sured as the ability to get things the participant needs,
to change her situation and control over elements such
as condom use. We hypothesise that access to HIVST will
lead to an improved sense of empowerment.
Adverse events
Adverse events are monitored and documented through-
out the study. The primary adverse events of concern
are psychological harm as a result of use of the HIV
self-test (eg, if participants test positive for HIV and are
not prepared for the results). Although UNAIDS has
recently indicated no evidence of serious adverse events
related to HIVST (ie, self-harm, violence or human
rights violations),28 occurrence of any such events are
reported to all principal investigators and the SOC
within 24 hours of study staff becoming aware of them.
Other adverse events include c oercive testing or unin-
tentional or unauthorised disclosure of HIV status,
which are similarly reported within 24 hours.
Statistical analysis
The primary analysis will be intention-to-treat. The
primary analysis for the quantitative data will involve a
mixed-effects multilevel logistic regression model to
account for clustering by peer educator group and study
site (participants nested in peer educators nested in
study sites). These models will include an indicator term
for study arm (ﬁxed distribution, direct distribution or
control). Outcomes, including past month HIV testing
and correct knowledge of status at 4 months, will be
modelled as dichotomous variables.
Qualitative data analysis
Qualitative data will be analysed using an iterative
descriptive approach to characterise and describe the
data at their natural level. After all interviews are tran-
scribed and translated, a codebook will be ﬁnalised and
transcripts will be coded in Dedoose, a cloud-based plat-
form for mixed-methods research.
Sample size considerations
The sample size calculation was based on the primary
end point, testing for HIV in the past month assessed at
the 1-month visit, and the secondary end point, propor-
tion of participants who correctly know their status at
the 4-month visit. Power calculations were performed
using methods for cluster randomised trials, with cluster-
ing by peer educator identity. We assume that 50% of
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participants will have tested in the past month in the
control arm based on previous estimates of HIV testing
behaviour among FSWs in Livingstone and
Chirundu.29 30 We estimate that in the control group,
∼70% of participants will correctly identify their HIV
status, assuming that the majority of those whose status is
unknown will report that they are negative, but that
approximately half of these individuals will actually be
positive. Assuming a 20% loss to follow-up and with 50
peer educators (clusters) per arm, a sample size of 300
participants per arm (900 total) will yield 89% power to
detect a risk ratio of 1.30 for recent testing and 94%
power to detect a risk ratio of 1.20 for correct status
knowledge, assuming a type I error probability of 0.05
and an intracluster correlation of 0.03.
Confidentiality
To protect participants’ conﬁdentiality, no identifying
information will be collected during any quantitative or
qualitative assessment and all collected data are
de-identiﬁed. A unique study identiﬁcation number will
be used to link data from an individual participant.
Participant identity codes are kept completely separately
from electronic data, in a locked cabinet in study ofﬁces.
The code will be destroyed on completion of the study.
Data management
Quantitative data are collected directly on a study tablet
via CommCare (Dimagi, Cambridge, Massachusetts,
USA), a Health Insurance Portability and Accountability
Act (HIPAA)-compliant, cloud-based platform for elec-
tronic data collection. Qualitative data are collected via
an audio recorder, which are transcribed and translated
verbatim. Qualitative audio recordings are destroyed on
completion of transcription and translation.
Dissemination plan
The results of this study will be disseminated to commu-
nity, policy and scientiﬁc stakeholders. A results commu-
nity meeting will be planned on completion of the study
at each study site, during which the results of the study
will be announced. We will also hold a meeting with the
Ministry of Health in Lusaka to disseminate our ﬁnd-
ings, and submit a report detailing the ﬁndings of the
study to inform policy. Finally, results will be shared with
the scientiﬁc community via presentation at inter-
national conferences and journal publication.
DISCUSSION
Despite the high risk and large burden of HIV among
FSWs, HIV testing and HIV status knowledge in this
population remain far from universal. A number of
complex barriers at multiple levels can limit access to
HIV testing for FSWs, including fear of stigma and
abuse, fear of loss of livelihood, and the ﬁnancial and
time costs of using traditional HIV testing services.
HIVST is a promising alternative HIV testing option for
FSWs, because it allows for a high degree of privacy, efﬁ-
ciency and ﬂexibility in HIV testing. The overarching
goal of the ZEST trial is to provide robust evidence for
the development of policy for implementation and
scale-up of HIVST in Zambia with a speciﬁc focus on
ensuring that this technology is accessible to FSWs.
Working in concert with the Ministry of Health in
Zambia and the WHO, this trial was speciﬁcally designed
to ﬁll a crucial gap in the evidence by answering two
questions: (1) Is HIVST an acceptable alternative to
standard HIV testing for FSWs? and (2) Will FSWs access
HIVST?
Question 1 is addressed through the direct distribu-
tion arm. In this arm, we will be able to assess whether
individuals directly given a test actually use the test. By
directly giving individuals the test, we are assessing best-
case scenario uptake, where there are as few barriers as
possible for individuals to access the test kit. The uptake
results from this arm of the study will give robust evi-
dence on whether HIVST is an acceptable alternative to
standard and currently available HIV testing services.
Coupled with qualitative data, we will be able to measure
both the uptake of HIVST and participant attitudes
towards HIVST. This will lead to an in-depth understand-
ing of why participants did or did not use the test, and
how participants view the role of HIVST for HIV testing
in the future.
Although uptake and acceptability of HIVST is an
important piece of evidence for HIVST policy, the
design of this study allows for measurement of a more
realistic scenario, in which participants must go to a
physical distribution point to collect their kit. Question 2
is thus addressed through the ﬁxed distribution arm.
This arm will measure the degree to which barriers to
acquiring the HIVST kit in the store affect acquisition
and use of the test. This will be tested by implementing
the project within existing drug stores and health posts,
without changing the hours or geographical locations of
existing services. The direct and ﬁxed distribution arms
will therefore give two complementary pieces of infor-
mation—ﬁrst, are participants using the test kits? and
second, are they able to access them independently?
A major strength of this study is that it does not rely
on clinic-based sampling or recruitment. A potential
beneﬁt of HIVST over existing HIV testing services is
that it may allow individuals who are not currently
engaged in care or who have never sought HIV testing
because of barriers to accessing care to test for HIV.
HIVST may therefore be a gateway to care for indivi-
duals who have previously been difﬁcult to engage in
care. By working through peer educators, rather than in
clinics, we will access a different subset of the popula-
tion. Peer educator programmes have been used in a
variety of settings with different sex worker populations
to increase HIV prevention knowledge.31–36 In many
cases, peer educators have unique access to and rapport
with FSWs. This study, therefore, is expected to enrol a
diverse population of FSWs that is most likely more
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generalisable than a clinic-based sample, while simultan-
eously allowing access to populations that may not cur-
rently access care.
A major concern with HIVST is the potential for
intimate partner violence, for example, if sexual part-
ners ﬁnd out about HIV status through the test. All parti-
cipants will be screened for intimate partner violence at
baseline, 1 and 4 months. Intimate partner violence is
very common in the FSW community, and those who
have experienced intimate partner violence will be eli-
gible to participate, although the risks of participating
are explained fully. Furthermore, during follow-up peer
education visits, peer educators will screen for intimate
partner violence, and they will also be available between
visits should any issues come up. Finally, a 24-hour tele-
phone line will be available to all participants for any
issues, including intimate partner violence, and referral
will be made to counselling if desired. All reports of
intimate partner violence will be reviewed to determine
if they are related to HIVST or trial participation. In this
study, we do not offer HIVST for FSWs to test with their
clients or other sexual partners. While it is possible that
partner testing could be a beneﬁt for some participants,
it could also put some at increased risk of violence. We
will collect detailed quantitative and qualitative data
about individuals with whom participants used the test,
if anyone. The results of this study are expected to yield
evidence of the impact of HIVST on safety end points,
in particular intimate partner violence.
Another safety concern with HIVST is the potential
for depression, anxiety or suicidality as a result of learn-
ing one’s HIV status. Structured interviews will contain
screening questions for depression, and peer educators
will perform a brief screening on depression, anxiety
and self-harm at each visit. Finally, participants will be
instructed to call the hotline should they need to discuss
their HIV result with anyone or receive counselling.
In conclusion, the results of this study are expected to
inform policy aimed at implementation and scale-up of
HIVST for FSWs in Zambia. This study will begin to
address critical gaps in the literature describing evidence
of HIV testing interventions for FSWs in Southern
Africa. We expect the results of this trial to have a policy
impact resulting in increased availability of HIVST in
Zambia.
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